Trial Profile
Bioequivalence Study Comparing Sotagliflozin Tablet Commercial Formulation (Test) and Sotagliflozin Tablet Development Formulation (Reference) in Healthy Male and Female Subjects Under Fasted Conditions
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Aug 2017
Price :
$35
*
At a glance
- Drugs Sotagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Sanofi
- 24 Aug 2017 Status changed from recruiting to completed.
- 10 Jul 2017 New trial record